Literature DB >> 33730582

Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed mice.

Jennifer E Kay1, Joshua J Corrigan1, Amanda L Armijo2, Ilana S Nazari3, Ishwar N Kohale4, Dorothea K Torous5, Svetlana L Avlasevich5, Robert G Croy1, Dushan N Wadduwage6, Sebastian E Carrasco7, Stephen D Dertinger5, Forest M White4, John M Essigmann8, Leona D Samson9, Bevin P Engelward10.   

Abstract

N-Nitrosodimethylamine (NDMA) is a DNA-methylating agent that has been discovered to contaminate water, food, and drugs. The alkyladenine DNA glycosylase (AAG) removes methylated bases to initiate the base excision repair (BER) pathway. To understand how gene-environment interactions impact disease susceptibility, we study Aag-knockout (Aag-/-) and Aag-overexpressing mice that harbor increased levels of either replication-blocking lesions (3-methyladenine [3MeA]) or strand breaks (BER intermediates), respectively. Remarkably, the disease outcome switches from cancer to lethality simply by changing AAG levels. To understand the underlying basis for this observation, we integrate a suite of molecular, cellular, and physiological analyses. We find that unrepaired 3MeA is somewhat toxic, but highly mutagenic (promoting cancer), whereas excess strand breaks are poorly mutagenic and highly toxic (suppressing cancer and promoting lethality). We demonstrate that the levels of a single DNA repair protein tip the balance between blocks and breaks and thus dictate the disease consequences of DNA damage.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA damage; DNA strand break; alkyladenine DNA glycosylase; cancer; liver; mutation; nitrosamine; replication-blocking lesion

Mesh:

Substances:

Year:  2021        PMID: 33730582      PMCID: PMC8527524          DOI: 10.1016/j.celrep.2021.108864

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  152 in total

1.  Error-prone lesion bypass by human DNA polymerase eta.

Authors:  Y Zhang; F Yuan; X Wu; O Rechkoblit; J S Taylor; N E Geacintov; Z Wang
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

Review 2.  Detailed review of transgenic rodent mutation assays.

Authors:  Iain B Lambert; Timothy M Singer; Sherri E Boucher; George R Douglas
Journal:  Mutat Res       Date:  2005-09       Impact factor: 2.433

3.  Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells.

Authors:  Deborah H Charych; Mazie Coyne; Asha Yabannavar; Jamie Narberes; Sylvia Chow; Marco Wallroth; Cynthia Shafer; Annette O Walter
Journal:  J Cell Biochem       Date:  2008-06-01       Impact factor: 4.429

4.  The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.

Authors:  M P Strout; G Marcucci; C D Bloomfield; M A Caligiuri
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 5.  Base excision repair and cancer.

Authors:  Susan S Wallace; Drew L Murphy; Joann B Sweasy
Journal:  Cancer Lett       Date:  2012-01-15       Impact factor: 8.679

6.  Characterization of the effects of cisplatin and carboplatin on cell cycle progression and DNA damage response activation in DNA polymerase eta-deficient human cells.

Authors:  Séverine Cruet-Hennequart; Sangamitra Villalan; Agnieszka Kaczmarczyk; Elaine O'Meara; Anna M Sokol; Michael P Carty
Journal:  Cell Cycle       Date:  2009-09-25       Impact factor: 4.534

7.  A Comprehensive Analysis of the Dynamic Response to Aphidicolin-Mediated Replication Stress Uncovers Targets for ATM and ATMIN.

Authors:  Abdelghani Mazouzi; Alexey Stukalov; André C Müller; Doris Chen; Marc Wiedner; Jana Prochazkova; Shih-Chieh Chiang; Michael Schuster; Florian P Breitwieser; Andreas Pichlmair; Sherif F El-Khamisy; Christoph Bock; Robert Kralovics; Jacques Colinge; Keiryn L Bennett; Joanna I Loizou
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423

8.  Mus81, Rhp51(Rad51), and Rqh1 form an epistatic pathway required for the S-phase DNA damage checkpoint.

Authors:  Nicholas Willis; Nicholas Rhind
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

9.  Parp1 protects against Aag-dependent alkylation-induced nephrotoxicity in a sex-dependent manner.

Authors:  Jennifer A Calvo; Mariacarmela Allocca; Kimberly R Fake; Sureshkumar Muthupalani; Joshua J Corrigan; Roderick T Bronson; Leona D Samson
Journal:  Oncotarget       Date:  2016-07-19

10.  Alkyladenine DNA glycosylase deficiency uncouples alkylation-induced strand break generation from PARP-1 activation and glycolysis inhibition.

Authors:  Fahad A Alhumaydhi; Debora de O Lopes; Diana L Bordin; Abdullah S M Aljohani; Cameron B Lloyd; Michael D McNicholas; Larissa Milano; Clara F Charlier; Izabel Villela; João Antonio P Henriques; Kathryn E Plant; Ruan M Elliott; Lisiane B Meira
Journal:  Sci Rep       Date:  2020-02-10       Impact factor: 4.379

View more
  2 in total

1.  AOP report: Development of an adverse outcome pathway for oxidative DNA damage leading to mutations and chromosomal aberrations.

Authors:  Eunnara Cho; Ashley Allemang; Marc Audebert; Vinita Chauhan; Stephen Dertinger; Giel Hendriks; Mirjam Luijten; Francesco Marchetti; Sheroy Minocherhomji; Stefan Pfuhler; Daniel J Roberts; Kristina Trenz; Carole L Yauk
Journal:  Environ Mol Mutagen       Date:  2022-05-03       Impact factor: 3.579

2.  Novel In Vivo CometChip Reveals NDMA-Induced DNA Damage and Repair in Multiple Mouse Tissues.

Authors:  Norah A Owiti; Joshua J Corrigan; Lee J Pribyl; Jennifer E Kay; Bevin P Engelward
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.